Go Deep
Conexeu Sciences Inc.
Conexeu Sciences Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 15,425 | -6.5 | 19.04 | 0.08 | 374.12 |
| Oct 2026 | 17,809 | -5.0 | 14.75 | 0.08 | 289.83 |
| Oct 2026 | 17,193 | -5.4 | 15.86 | 0.08 | 311.95 |
| Oct 2026 | 17,996 | -4.9 | 14.42 | 0.08 | 283.50 |
| Oct 2026 | 17,086 | -5.5 | 16.05 | 0.08 | 314.96 |
| Oct 2026 | 16,989 | -5.4 | 15.91 | 0.08 | 311.49 |
Conexeu Sciences Inc. Quarterly Results
| Line Item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -7,725,651.0 | -2,304,283.0 | -1,718,823.0 | -1,876,873.0 |
| EPS | -0.3 | -0.1 | -0.1 | — |
Conexeu Sciences Inc. Revenue & Profit: Last 2 Years
| Line Item | Oct 2025 | Oct 2024 |
|---|---|---|
| Revenue | 0.0 | 0.0 |
| Net Profit | -3,923,557.0 | -471,867.0 |
| EPS | -0.2 | -0.0 |
Conexeu Sciences Inc. Balance Sheet
| Line Item | Oct 2025 | Oct 2024 |
|---|---|---|
| Total Assets | 7,688,711.0 | 533,940.0 |
| Total Liabilities | 336,018.0 | 438,976.0 |
| Total Equity | 7,352,693.0 | 94,964.0 |
Owes vs Owns
Conexeu Sciences Inc. owed $0.18 for every $1 it owned in Jul 2026, down from $0.82 in Oct 2024.
| Period | Jul 2026 | Oct 2025 | Oct 2024 |
|---|---|---|---|
| Owes vs Owns | 0.18× | 0.04× | 0.82× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Conexeu Sciences Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Oct 2025
Cash & short-term investments 62.5%Receivables 27.0%Intangible assets 2.3%Other assets 8.0%
How it's funded — Oct 2025
Payables 3.3%Other liabilities 1.0%Shareholders' equity 95.6%
| Line Item | Oct 2025 | Oct 2024 |
|---|---|---|
| Assets | ||
| Cash & short-term investments | 4.8 | 0.3 |
| Receivables | 2.1 | 0.0 |
| Inventory | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.0 | 0.0 |
| Intangible assets | 0.2 | 0.2 |
| Long-term investments | 0.0 | 0.0 |
| Other assets | 0.6 | 0.0 |
| Liabilities & equity | ||
| Short-term debt | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.1 |
| Payables | 0.3 | 0.3 |
| Other liabilities | 0.1 | 0.0 |
| Shareholders' equity | 7.4 | 0.1 |
| Net tangible assets | 7.2 | -0.1 |
Conexeu Sciences Inc. Cash Flow
| Line Item | Oct 2025 | Oct 2024 |
|---|---|---|
| Operating Activities | -1,669,975.0 | -225,439.0 |
| Investing Activities | -89,994.0 | 0.0 |
| Financing Activities | 6,283,384.0 | 534,637.0 |